Aimei Health: Nasdaq Sends AFJK 60-Day Notice
Aimei Health received a Nasdaq deficiency notice after missing the May 15 deadline for its March-quarter 10-Q filing. Shares traded at $42.18 in pre-market activity ahead of Thursday’s U.S. session. The company has 60 days from the May 19 notice to regain compliance or risk delisting. Aimei is also seeking to complete a merger with United Hydrogen Group, pending regulatory approval.